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Cross-sectional studies have found that obesity is associated with low intellectual ability and neuroimaging
abnormalities in adolescence and adulthood. Some have interpreted these associations to suggest that obesity
causes intellectual decline in the first half of the life course. We analyzed data from a prospective longitudinal
study to test whether becoming obese was associated with intellectual decline from childhood to midlife. We used
data from the ongoing Dunedin Multidisciplinary Health and Development Study, a population-representative birth
cohort study of 1,037 children in New Zealand who were followed prospectively from birth (1972–1973) through
their fourth decade of life with a 95% retention rate. Intelligence quotient (IQ) was measured in childhood and
adulthood. Anthropometric measurements were taken at birth and at 12 subsequent in-person assessments. As
expected, cohort members who became obese had lower adulthood IQ scores. However, obese cohort members
exhibited no excess decline in IQ. Instead, these cohort members had lower IQ scores since childhood. This
pattern remained consistent when we accounted for children’s birth weights and growth during the first years of
life, as well as for childhood-onset obesity. Lower IQ scores among children who later developed obesity were
present as early as 3 years of age. We observed no evidence that obesity contributed to a decline in IQ, even among
obese individuals who displayed evidence of the metabolic syndrome and/or elevated systemic inflammation.
cognitive aging; intellectual decline; intelligence quotient; IQ decline; life course; longitudinal study; metabolic
syndrome; obesity
Abbreviations: BMI, body mass index; CI, confidence interval; hsCRP, high-sensitivity C-reactive protein; IQ, intelligence quotient;
RR, relative risk; SE, standard error.
Obesity is a global public health challenge and a leading
cause of preventable death (1). Obesity is a well-established
risk factor for both cardiovascular and metabolic diseases.
Recent research has suggested that obesity may damage not
only the body but also the brain.
Two streams of research have given rise to the hypothesis
that obesity can harm the brain and compromise perform-
ance on intelligence tests. The first stream of research com-
prises brain imaging studies that document structural and
functional abnormalities in obese individuals that are appar-
ent as early as adolescence (2–5) and studies that show that
obese children and adults have lower intelligence quotients
(IQs) than do lean controls (6, 7). Together, these findings
have been interpreted to suggest that obesity may harm key
brain regions and functions that support the IQ (8). This inter-
pretation has entered popular discourse through media head-
lines such as “Extreme obesity in tots tied to low IQ” (9);
“Obesity can lower children’s IQ” (10); “Obesity might lower
teens’ thinking skills, study suggests” (11); and “The greater
your weight, the lower your IQ, say scientists” (12). The conclu-
sion that obesity damages the IQ during the first half of the life
course is premature.Because extant studieswere cross-sectional,
they could not establish the temporal ordering of obesity and
lowIQ.Toadvance research and refinecausal inferences about
the obesity–IQ association, life-course studies are needed that
use individuals as their own controls. Such studies can test
within-individual changes in IQ from childhood, before the
onset of obesity, to adulthood, after obesity develops (2, 13).
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The second stream of research comprises studies that follow-
up cohorts established in midlife. Most of these studies found
that adults who were obese in midlife were more likely to suf-
fer cognitive decline and develop dementia than were their lean
peers (14–16). This finding has given rise to theories that pre-
vention and treatment of obesity may protect older adults from
cognitive decline (17–19). This conclusion is also premature.
Low IQ in childhood is a risk factor for both obesity and later-
lifecognitivedecline, and itmayaccount for someof theobserved
association between the 2 factors (20–25). To advance research
and refine causal inferences about the obesity–dementia associ-
ation in the second half of the life course, it is important to
understand the interplay between cognitive function and cardio-
metabolic processes in the first half of the life course. For this
reason, Epidemiologic Reviews recently noted that to “better
understand the direction of the association between obesity and
cognitive aging, longitudinal studies are needed . . . preferably
starting in early life” (26, p. 30).
We conducted a prospective life-course study of the associa-
tion between obesity and IQ decline using data from a birth
cohort of 1,037 individuals followed prospectively through
38 years of age. Cohort members completed tests of cogni-
tive ability at ages 3, 7, 9, and 11 years and again in adult-
hood at age 38 years. Obesity was assessed at regular intervals
across the 4 decades of follow-up. To advance research on the
association between obesity and low IQ, we used these data
to test the hypothesis that cohort members who developed
obesity between the ages of 11 and 38 years would experi-
ence a decline in IQ greater than that of their peers who were
neverobese.Measuresofweight andcognitive abilitybetween
birth and 3 years of age were also used to push back the age
window for the ascertainment of temporal ordering. Measures
of metabolic and inflammatory abnormalities were used to
differentiate severe obesity cases from persons who had ele-




Participants were members of the Dunedin Multidisciplin-
ary Health and Development Study, a longitudinal investiga-
tion of health and behavior in a complete birth cohort. Study
members (n = 1,037; 91% of eligible births; 52% male) were
all individuals born between April 1972 and March 1973 in
Dunedin, New Zealand, who were eligible for the longitudi-
nal study based on residence in the province at 3 years of
age and who participated in the first follow-up assessment at
3 years of age. The cohort represents the full range of socio-
economic statuses in the general population of New Zealand’s
South Island and is primarily white (27). Assessments were
carried out at birth and at ages 3, 5, 7, 9, 11, 13, 15, 18, 21,
26, 32, and 38 years, at which time 95% of the 1,007 study
members who were still alive took part. At each assessment
wave, study members were brought to the Dunedin research
unit for a full day of interviews and examinations. The Otago
Ethics Committee approved each phase of the study and
informed consent was obtained from all study members. The
studyprotocolwas approvedby the institutional ethical review
boards of the participating universities.
Measures
Intelligence quotient. IQ is a highly reliable measure of
general intellectual functioning that captures overall ability
across differentiable cognitive functions. Participants’ IQ scores
were assessed in childhood at ages 7, 9, and 11 years and
again in adulthood at age 38 years. We measured IQ decline
by comparing scores from the individually administered
Wechsler Intelligence Scale for Children-Revised (averaged
across ages 7, 9, and 11 years) (28) with those from the
Wechsler Adult Intelligence Scale-IV (29). Both had a mean
score of 100 and a standard deviation of 15. In addition to
the Wechsler Intelligence Scale for Children-Revised and
Wechsler Adult Intelligence Scale-IV, we administered the
Rey Auditory Verbal Learning Test (30), the Trail Making
Test (31), and the Grooved Pegboard Test at ages 13 and 38
years to assess memory, executive functioning, and motor
functioning, respectively (30).
Early childhood cognitive ability measure. Cohort mem-
bers completed the Peabody Picture Vocabulary Test (32)
during their assessment at 3 years of age. The Peabody test
prompts children with vocabulary words and asks them to iden-
tify the corresponding picture from an array during a roughly
30-minute assessment. Peabody IQ scores were strongly pre-
dictive of subsequent IQ test performance (r = 0.52).
Obesity phenotypes
Obesity. Cohortmembers’heights andweightsweremea-
sured at each assessment. Height was measured to the nearest
millimeter using a portable Harpenden Stadiometer (Holtain,
Crymych, United Kingdom). Weight was recorded to the
nearest 0.1 kg at ages 3, 5, 7, 9, 11, 13, 15, 21, 26, 32, and
38 years using calibrated scales. Individuals were weighed
in light clothing. BMI was measured as weight in kilograms
divided by height in meters squared. Through 15 years of
age, obesity was defined using the 90th percentile of the US
Centers for Disease Control and Prevention reference BMI
distributions for boys and girls (http://www.cdc.gov/growth
charts/). Subsequently, obesity was defined as a BMI of 30
or higher. During the 25-year interval between IQ measure-
ments (ages 13–38 years), 28% of the cohort became obese
(n = 289). This prevalence is in line with the general New
Zealand population (in the most recent Ministry of Health
report, obesity prevalence was 28% for New Zealanders 15
years of age or older) (33).
Severe obesity. We defined cases of severe obesity at
ages 32 and 38 years using assessments of metabolic syn-
drome and systemic inflammation, which are established clin-
ical features of severe obesity (34). Metabolic syndrome was
assessed using measurements of 5 biomarkers: 1) high waist
circumference (≥88 cm for women, ≥102 cm for men),
2) high blood pressure (≥130/85 mmHg), 3) low high-density
lipoprotein cholesterol level (<50 mg/dL forwomen, <40 mg/dL
for men), 4) high glycated hemoglobin (≥5.7%), and 5) high
triglyceride level (≥200 mmol/L). Biomarker assessments
have been described in detail previously (35, 36). Cohort
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members with high-risk values for 3 or more biomarkers were
defined as having the metabolic syndrome (37).
Elevated systemic inflammation was assessed using assays
of high-sensitivity C-reactive protein (hsCRP) in blood. As
previously described (36), hsCRP was measured with a
Hitachi 917 analyzer (Roche Diagnostics, GmbH, D-68298,
Mannheim, Germany) using a particle-enhanced immuno-
turbidimetric assay. The Centers for Disease Control and
Prevention/American Heart Association definition of high
cardiovascular risk (hsCRP >3 mg/L) was used to identify
our risk group (38).
Of the original cohort, 92% had available data on severe
obesity phenotypes (n = 969). Within this group, 18% had
severe obesity, defined as having a BMI of 30 or higher and
either the metabolic syndrome or a hsCRP level >3 mg/L
(n = 181).
Early childhood weight measures. Individual differences
in obesity risk emerge during gestation and are further estab-
lished during infancy and childhood through accelerated
growth trajectories (39, 40). We assessed rapid early life
growth that predisposed participants to obesity using data on
1) weight at birth; 2) rate of weight gain in early childhood
assessed as the difference between weight at birth (from hos-
pital records) and weight at 3 years of age; and 3) age and
BMI at adiposity rebound, calculated as the nadir of each
cohort member’s childhood BMI growth curve fitted over
ages 3–13 years (41). Collectively, these measures explained
18% of BMI variance at the end of follow-up and predicted
obesity onset with moderate sensitivity and specificity (C
statistic = 0.75, 95% confidence interval (CI): 0.71, 0.79).
Obesity risk factors. The socioeconomic statuses of cohort
members’ families were measured using a 6-point scale that
assessedparents’occupational statuses, definedbasedonaver-
age income and educational levels derived from the New
Zealand Census. The highest occupational status of either par-
entwas averaged across the childhood assessments (42). Family
history of obesity was derived from heights and weights of the
cohort members’ parents that were assessed via parent report
when cohort members were 11 years of age. BMIs were cal-
culated and standardized by sex, and maternal and paternal
standardized scores were averaged to create a single family
history score (41).
Analysis
All analyses included the 913 cohort members with avail-
able childhood and adulthood IQ data. Surviving cohort
members for whom we did not have IQ data at either period
did not differ from the analysis sample in terms of obesity or
their available IQ measurement. Because the IQ is an age-
standardized measurement, we were able to compare scores
in childhood and adulthood to quantify IQ decline. We used
linear regression models to test the hypothesis that develop-
ing obesity caused a decline in IQ. We regressed adult IQ
scores on obesity status and childhood IQ to estimate the
change in IQ associated with becoming obese. The regres-
sion model tested whether, after adjustment for baseline IQ,
becoming obese was associated with having a lower adult
IQ. This approach yielded identical results to so-called “dif-
ferences in differences” models that tested a time-by-obesity
interaction to predict IQ. These models used panel datasets
that included 2 observations per individual to test for differ-
ences in IQ change from 11 to 38 years of age in the group
of participants who developed obesity as compared with the
group who remained lean. The regression models included a
main effect term for the time elapsed between IQ measure-
ments, a main effect term for a dummy variable that coded
whether the study member became obese during follow-up,
and a product term that tested the interaction between these
2 variables. Because we did not find that obesity was associ-
ated with a decline in IQ, we next tested the hypothesis of
reverse causation, that is, that having a low IQ predisposes
children to develop obesity. We used Cox models to regress
time to obesity onset on childhood IQ and covariates to derive
hazard ratios. We used multinomial logit models to regress
obesity outcomes on childhood IQ and covariates to derive
relative risks. The multinomial logit model showed the prob-
abilities that children would 1) remain lean, 2) develop non-
severe obesity, or 3) develop severe obesity with metabolic
syndrome or elevated systemic inflammation. Relative risks
were derived using the group who remained lean as the refer-
ence group. Effect sizes for analyses of the cognitive testing
measure are presented in standardized IQ points (mean, 100;
standard deviation, 15). For analyses of obesity outcomes,
effect sizes are reported for a 1-standard-deviation change in
IQ score. Because the sample is a representative birth cohort,
it forms its own test norms for the purpose of estimating
effect sizes. Regressionmodelswere adjusted for sex to account
for differences in obesity prevalence. Statistical analyses were
conducted using Stata, version 12.0 (Stata Corp. LP, College
Station, Texas).
RESULTS
Is becoming obese associated with IQ decline?
Similar to what was seen in prior cross-sectional studies
of adults, we found that cohort members who became obese
had lower adult IQ scores than did their peers who remained
lean during follow-up (for the obese group, adult IQ score =
96.93 (standard error (SE), 0.92) and for the lean group, adult
IQ score = 101.28 (SE, 0.58); P = 0.001 for difference). How-
ever, cohort members who developed obesity did not have a
greater change in IQ score than those who remained lean
over the 25-year period; in both groups, the average change
in IQ was less than 0.10 IQ points (P = 0.831 for difference).
Instead, cohort members who became obese had lower IQ
scores at childhood baseline than did their lean peers (for the
group who became obese, childhood IQ score = 97.01 (SE,
0.93) and for the lean group, childhood IQ score = 101.25
(SE, 0.58); P = 0.001 for difference) (Figure 1A).
It was possible that early-onset obesity had already
affected IQ levels by the time of childhood baseline testing
(at ages 7–11 years). To rule this out, we repeated our analy-
sis, excluding cases with obesity onset through age 11 years
(n = 120). Results were unchanged. Compared with their peers
who remained lean, cohort members in whom the onset of
obesity occurred for the first time during the ages of 13–38
years had lower IQ scores at childhood baseline (IQ = 96.41,
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SE, 1.12) and at adult follow-up (IQ = 96.58, SE, 1.08), but
there was no evidence of a larger change in IQ (Figure 1B).
It was possible that children on a developmental trajectory
to become obese were already suffering IQ decline by the
time of the childhood baseline assessment. To rule this out,
we performed a statistical adjustment to our analysis to take
into account each child’s developmental predisposition to
obesity as measured by their weight at birth, their weight
gain between birth and age 3 years, and their age and BMI at
adiposity rebound. Results were unchanged by statistical
adjustment for these indicators of early growth predisposing
to obesity: Cohort members who became obese had child-
hood IQs that were 4.27 (SE, 1.27) points lower and adult
IQs that were 4.35 (SE, 1.24) points lower than those of
cohort members who remained lean (Figure 1C). As a final
check,wealsoexaminedscoresonthePeabodyPictureVocab-
ulary IQ test, which cohort members had completed at 3
years of age. Cohort members who later became obese already
had IQs at 3 years of age that were lower than those of their
peerswhowould remain lean (for the group that became obese,
Peabody IQ = 97.80 (SE, 0.96); for the never-obese group,
Peabody IQ = 100.91 (SE, 0.60); P = 0.006).
It was possible that we did not observe obesity cases of
sufficient severity to cause IQ decline. To rule this out, we
compared childhood and adulthood IQ scores of cohort mem-
bers who never developed obesity with those of cohort mem-
bers who developed severe obesity, defined as having a BMI
of 30 or higher in addition to the metabolic syndrome or ele-
vated systemic inflammation (hsCRP >3 mg/L). Figure 1D
shows that children who later developed severe obesity had
lower IQ scores at childhood baseline and at adult follow-up
but exhibited no excess IQ decline (childhood IQ = 96.41
(SE, 1.21) and adult IQ = 96.18 (SE, 1.14)). Results were simi-
lar for tests of memory, executive function, and motor func-
tion. Cohort members who developed obesity scored lower
on neuropsychological functioning tests at baseline (13 years
of age) and at follow-up (38 years of age) but exhibited no
excess neuropsychological functioning decline (Table 1).
Is lower childhood IQ associated with becoming obese?
Having found that lower IQ temporally preceded the onset
of obesity, we turned to the question of whether having a
lower IQ predisposed children to become obese. Children
with lower IQ scores were more likely to become obese over
the following 3 decades; a 15-point (1 standard deviation)
difference in IQ between children predicted a 27% differ-











































































Figure 1. Association of obesity and longstanding cognitive deficit from childhood, Dunedin Multidisciplinary Health and Development Study,
1972–2012. A) Change in intelligence quotient (IQ) from childhood to adulthood in Dunedin cohort members who remained lean (n = 644; gray
dots) and cohort members who became obese during follow-up between 11 and 38 years of age (n = 269; black dots). B) The same data, exclud-
ing cases in whom the onset of obesity occurred by 11 years of age (gray dots, lean group; black dots, the group who first became obese after 11
years of age; n = 187). C) IQ change from childhood to adulthood in the lean (gray dots) and obese (black dots) groups with adjustment for early
growth factors that predispose persons to obesity (measured by weight at birth, weight gain between birth and 3 years of age, and age and body
mass index at adiposity rebound). D) IQ change in 3 groups: those who remained lean (gray dots); those who became obese but who did not man-
ifest the metabolic syndrome or elevated systemic inflammation (n = 94; black dots); and those who developed severe obesity with metabolic syn-
drome or elevated systemic inflammation (n = 170; black diamonds). Data in D exclude 5 obese cases for whom the metabolic syndrome and
systemic inflammation could not be evaluated because of missing phlebotomy procedures.
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95% CI: 1.10, 1.48). Specifically, children with lower IQs
were at an increased risk of developing severe obesity with
metabolic syndrome or elevated inflammation (relative risk
(RR) = 1.40, 95% CI: 1.15, 1.71). This association was not
fully explained by the children’s developmental predisposi-
tion to obesity (adjusted RR = 1.47, 95%CI: 1.19, 1.82), socio-
economic characteristics of the households in which the
children grew up (adjusted RR = 1.30, 95% CI: 1.05, 1.61),
children’s family histories of obesity (adjusted RR = 1.34,
95% CI: 1.09, 1.65), or adjustment for all of these risk factors
(adjusted RR = 1.34, 95% CI: 1.06, 1.70). Figure 2 shows the
associationsbetweenchildhood IQandobesityonset (Figure1A)
and risk for developing severe obesity (Figure 1B).
DISCUSSION
Reports based on cross-sectional study designs have sug-
gested that developing obesity increases risk of a decline in
IQ among adolescents and adults. These findings have raised
alarm bells, and not just in the public-health community. If
obesity does cause a decline in IQ, it could represent a threat
to the ability of today’s children to compete in tomorrow’s
information-intensive economy. There is no doubt that com-
bating the obesity epidemic is a critical national priority.How-
ever, our data, which are from a population-representative
cohort of 1,000 children followed for 4 decades, are not con-
sistent with the hypothesis that obesity causes a decline in IQ
in the first half of the life course. Instead, they show that the
IQ deficits of obese adults were already present in childhood.
Children in our cohort who later developed obesity showed
no IQ decline, but they did have lower IQs at baseline as
compared with their peers who remained lean over 3 decades of
follow-up. This pattern remained consistent when we restricted
our sample to only lean children and when we accounted for
differences in children’s birth weight and in their growth during
the first years of life. Differences in mental ability between chil-
dren who remained lean and those who later developed obesity
were present as early as 3 years of age. Even when we restricted
our obese group to comprise only participants with severe obe-
sity and the metabolic syndrome or elevated systemic inflamma-
tion, we observed no evidence that obesity contributed to IQ
decline.
Our data are consistent with the hypothesis that cross-
sectional associations between obesity and IQ arise because
children with lower IQs are at greater risk of becoming obese
(43, 44). Prior reports on correlations between low childhood
IQ and later obesity risk included only a single childhood
measurement of IQ and could not rule out the possibility that
children’s IQs declined following the onset of obesity (21–
23). We followed a population-representative birth cohort for
whom we had measurements of IQ in childhood before obe-
sity onset and who were retested in midlife after some cohort
members had become obese. Therefore, unlike those from
previous studies, our data show that becoming obese in ado-
lescence or young adulthood does not cause IQ decline as of
midlife.
We acknowledge some limitations of our study. First,
although our study shows a temporal precedence of low IQ
over obesity, it does not establish causation. The apparent
relationship between low childhood IQ and increased risk of
obesity could arise from a common cause (45). Second, our
study is right-hand censored at age 38 years. There are reports
of obesity as a contributor to cognitive decline observed in
elderly patients and those with dementing illnesses (16, 46),
which implicates metabolic or inflammatory mechanisms
(47, 48). Our cohort is not old enough for us to try to deter-
mine whether obesity poses risk for dementia. However, our
observation that individuals with metabolic/inflammatory
Table 1. Association of Obesity With Change in Intelligence Quotient and Neuropsychological Functioning, Dunedin Multidisciplinary Health and
Development Study, 1972–2012
Measure
Mean Childhood and Adulthood IQ and Neuropsychological Test Scores by
Body Composition in Standardized IQ Units
Lean (n = 644)a Obese (n = 269)b Severely Obese (n = 170)c
Child Adult Changed Child Adult Changed Child Adult Changed
IQ 101.25 101.28 0.04 97.01*** 96.93*** −0.08 96.41*** 96.18*** −0.23
Verbal IQ 100.94 101.05 0.11 97.74** 97.47** −0.27 97.15** 96.82** −0.33
Performance IQ 101.31 101.24 −0.08 96.85*** 97.03*** 0.19 96.35*** 96.42*** 0.07
Neurocognitive tests
Rey Delayed Recall 100.70 100.41 −0.29 98.38* 99.05 0.67 97.73* 98.13 0.40
Trails B 100.80 100.89 0.09 98.14* 97.94* −0.21 96.53** 97.77* 1.24
Grooved Peg Board 101.68 101.40 −0.28 96.10*** 96.76*** 0.66 94.46*** 94.96*** 0.49
Abbreviation: IQ, intelligence quotient.
*P < 0.05; **P < 0.01; ***P < 0.001 versus the lean group.
a Cohort members in the lean group did not have a body mass index (weight (kg)/height (m)2) in excess of the cutoff for obesity during the
course of follow-up.
b Cohort members in the obese group had a body mass index of 30 or higher at 1 or more assessments during follow-up.
c Cohort members in the severely obese group had a body mass index of 30 or higher at 1 or more measurements during follow-up and were
diagnosed with the metabolic syndrome or showed evidence of having elevated systemic inflammation (high-sensitivity C-reactive protein level
>3 mg/L).
d One point = 1/15 of 1 standard deviation.
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obesity in midlife have already had a 5-point IQ deficit since
childhood means that it is necessary to control statistically
for childhood IQ before estimating the effect size for the
attributable risk of obesity to late-life cognitive decline (49),
lest that risk be over-estimated. Third, our study lacked neu-
roimaging data, and we were limited to neuropsychological
testing to assess brain functioning. However, our finding sug-
gests that studies of structural and functional brain abnor-
malities in obese adults should also consider the question of
temporal order (2).
Despite these limitations, our study has important impli-
cations for obesity research and policy. After reports from
cross-sectional studies that obesity is associated with a lower
IQ, much research attention has been invested to elucidate
the pathophysiology by which obesity causes decline in men-
tal ability (50–55). Our findings suggest that similar atten-
tion should be focused on understanding why children with
lower IQs have an increased risk of obesity. A further impli-
cation of our results is that research is needed to investigate
whether premorbid differences in intellectual functioning
account for the link betweenmidlife obesity and late-life demen-
tia. Evidence from prospective studies has shown that chil-
dren with lower IQs have a greater risk of dementia (24, 25).
To date, studies linking midlife obesity with dementia have
not accounted for differences in premorbid IQ scores (13, 26).
Theories of why obese adults are at greater risk for dementia
focus onmetabolic dysregulation and elevated systemic inflam-
mation (56, 57). Our results indicate that, at least in the first
half of the life course, these exposures do not harm the IQ, but
they do occur more often in individuals who have had low
IQ since childhood. Collectively, this evidence suggests the
hypothesis that intellectual functioning in childhood indexes
risk for poor midlife physical health and accelerated cogni-
tive aging and may confound associations between the 2.
Future studies should test for such confounding and seek to
better understand brain health as driver of the aging process,
not just an outcome.
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temic inflammation, Dunedin Multidisciplinary Health and Development Study, 1972–2012. A) Cumulative hazard functions for Dunedin cohort
children with low intelligence quotients (IQ = 85), average IQs (IQ = 100), and high IQs (IQ = 115). Hazards were estimated using a Cox regression
model that was adjusted for sex. Children with lower IQs were more likely to develop obesity and became obese earlier in life (for each 1-standard-
deviation decrease in IQ, hazard ratio = 1.28, 95% confidence interval: 1.10, 1.48). B) Predicted probability of obesity as function of childhood IQ.
Predicted probabilities were estimated using a probit regression model that was adjusted for sex. Children with lower IQs had an increased risk of
developing severe obesity with metabolic syndrome or elevated inflammation (for each 1-standard-deviation decrease in IQ, relative risk = 1.40,
95% confidence interval: 1.15, 1.71). Bars, 95% confidence intervals.
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